Completed PHASE4 INTERVENTIONAL 2-arm NCT03597919

A Study of Immunogenicity and Seroconversion With Sabin IPV Schedules in China.

A Study of Immunogenicity and Seroconversion With Sabin Inactivated Polio Vaccine Schedules in China.

Sponsor: Centers for Disease Control and Prevention, China

Interventions Sabin IPV

Updated 6 times since 2018 Last updated: Jun 23, 2020 Started: May 28, 2018 Primary completion: Sep 30, 2019 Completion: Jan 15, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Poliomyelitis, this trial is completed. The trial is conducted by Centers for Disease Control and Prevention, China and has accumulated 6 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jul 2020 — Jan 2021 [monthly]

Completed PHASE4

Status: Enrolling By Invitation → Completed
Sep 2019 — Jul 2020 [monthly]

Enrolling By Invitation PHASE4

▶ Show 1 earlier version

Aug 2018 — Sep 2019 [monthly]

Enrolling By Invitation PHASE4

First recorded

May 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centers for Disease Control and Prevention, China
Shandong Province Centers for Disease Control and Prevention
World Health Organization

Data source: Centers for Disease Control and Prevention, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jinan, China